Passion Innovation Group

"A business that makes nothing but money is a poor business"
Henry Ford


Regeneus develops technologies based on the use of the body‘s own healing powers, stem cells and their secretions. They are a pioneer in regenerative medicine for both, human and animal health. Their product pipeline in human health includes Progenza (an allogenic arthritis drug in a first in human trial), RGSH4K (a human cancer vaccine in a safety trial) and a secretions based cream for skin conditions. In animal health, they work on Cryoshot (an injection for arthritis in canines in co-development with a veterinary company) and on KVAX (an autologous tumor cell based cancer vaccine for animals).